Mukanov , K., Mukantayev , K., & Tarlykov , P. (2018). GPR161 RECEPTOR AS A NOVEL TARGET FOR ANTIBODY-BASED IMMUNOTHERAPY OF TRIPLE-NEGATIVE BREAST CANCER. Eurasian Journal of Applied Biotechnology, (1). https://doi.org/10.11134/btp.1.2018.4